tbuckley/cabot-search huggingface dataset:
Physical Diagnosis
Journal: JAMA (1935)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Announcement: National Bullying Prevention Awareness Month — October 2016
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

Bullying among youths is defined as any unwanted aggressive behavior by another youth or group of youths who are not siblings or current dating partners and involves an observed or perceived power imbalance, and is repeated multiple times or is highly likely to be repeated (1). As a form of youth violence, bullying can include aggression that is physical (hitting or tripping), verbal (name calling or teasing), or relational/social (rumor spreading or leaving out of a group). Electronic aggression, or cyber-bullying, is bullying that occurs through the Internet, cellphone technology, and social media (e.g., e-mail, website, text messaging, posting videos, or pictures) (2).
Benzo(a)pyrene Diolepoxide-DNA Adducts Detected by Synchronous Fluorescence Spectrophotometry
Authors: Kirsi Vahakangas, Glennwood Trivers, Marilyn Rowe, Curtis C. Harris
Journal: Environmental Health Perspectives (1985)

Using benzo(a)pyrene (BP) as a model carcinogen we are currently applying a fluorescence technique to detect the very low levels of carcinogen-DNA adducts in human populations due to environmental exposure. In synchronous fluorescence spectrophotometry for detection of BP-diol epoxide-DNA, excitation and emission wavelengths are scanned simultaneously with a fixed wavelength difference (delta lambda) of 34 nm. Compared to conventional fluorescence methods only one peak emerges because excitation and emission peaks have to match delta lambda to show. Because of the quenching effect of DNA, samples are hydrolyzed by acid. After this, BP-diol epoxide (BPDE)- -modified DNA gives a peak at the same wavelength and of the same fluorescence yield as BP-tetrols. When DNA from peripheral blood lymphocytes of 44 coke oven workers were analyzed, 10 had a sharp peak at 379. Among 36 coke oven workers from another factory, 4 had detectable levels of adducts. A much smaller percentage of samples was positive in a group of aluminum plant workers. We have also found BPDE-DNA adducts in DNA from pulmonary alveolar macrophages and peripheral blood lymphocytes from tobacco smokers and some of the nonsmokers.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis
Journal: New England Journal of Medicine (2020)

We conducted a pragmatic, nonblinded, noninferiority, randomized trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centers. The primary outcome was 30-day health status, as assessed with the European Quality of Life–5 Dimensions (EQ-5D) questionnaire (scores range from 0 to 1, with higher scores indicating better health status; noninferiority margin, 0.05 points). Secondary outcomes included appendectomy in the antibiotics group and complications through 90 days; analyses were prespecified in subgroups defined according to the presence or absence of an appendicolith.
Impact of intravenous nicorandil on coronary microvascular function in patients with acute myocardial infarction: Study with Doppler guidewire Koichi Yamamoto, Hiroshi Ito, Katsuomi Iwakura, Yasunori Shintani, Akinobu Katoh, Masashi Ikushima, Shigeo Kawano, Yorihiko Higashino, Kenshi Fujii. Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan
Journal: Journal of the American College of Cardiology (2001)
Reply
Authors: Peter A. Campochiaro, Gulnar Hafiz, Tahreem A. Mir, Adrienne W. Scott, Sharon Solomon, Ingrid Zimmer-Galler, Akrit Sodhi, Elia Duh, Howard S. Ying, Adam S. Wenick, Syed Mahmood Shah, Diana V. Do, Quan D. Nguyen, Saleema Kherani, Raafay Sophie
Journal: Ophthalmology (2016)
Important Steps in Examining the Breasts
Journal: CA A Cancer Journal for Clinicians (1956)

Carcinoma of the inner lower sector of the right breastâ€"breasts symmetrical with arms at sides; indentation in the contour of breast with arms raised.Forward-bending maneuverâ€"a good way of demonstrat ing retraction.The patient's arms are supported by the doctor's hands.Forward bending shows the carcinoma distorting the inner contour of the breast. 54Important Steps in Examining the Breasts
Hepatitis C
Authors: Kieran Walsh
Journal: BMJ (2004)

extremely high levels of anxiety, but we do not know if this association is causal. Limitations of studyThe generalisability of the results is limited by the sample.Although the response rate of 63% is good for a mailed survey, 16 the sample under-represents women from ethnic minority groups and women with no educational qualifications.Given the association between educational level, knowledge, and understanding of complex health information, 17 our study could under-represent the distress that HPV testing can cause in general population samples of women undergoing cervical screening. ConclusionStudies are needed to determine, firstly, how to avoid some of the anxiety, distress, and concern caused by positive results on HPV testing and, secondly, how to provide some reassurance for women receiving negative HPV results.This study forms part of the independent evaluation of the HPV/LBV pilot in England,
Pulmonary Tuberculosis. Its Modern and Specialized Treatment.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
EUGENIC LEGISLATION.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ibopamine: A Drug That Has Opposite Effects Depending on the Severity of a Patient's Disease
Journal: Annals of Internal Medicine (2001)

Summaries for Patients3 April 2001Ibopamine: A Drug That Has Opposite Effects Depending on the Severity of a Patient's DiseaseSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-134-7-200104030-00005 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Ibopamine is a drug that was used in Europe to treat heart failure, a condition in which the heart cannot pump blood normally. In 1995, a study showed that ibopamine increased death rates in patients who had moderate to severe heart failure. In September 1995, doctors and pharmacists in the Netherlands were officially notified that ibopamine should be used only in patients with mild heart failure. Moreover, the official recommendations for when to use ibopamine were changed according to whether patients had mild or severe heart failure. Whether ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Confounding by Contraindication in a Nationwide Cohort Study of Risk for Death in Patients Taking Ibopamine.” It is in the 3 April 2001 issue of Annals of Internal Medicine (volume 134, pages 569-572). The authors are H Feenstra, RE Grobbee, BA in't Veld, and BHCh Stricker.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoConfounding by Contraindication in a Nationwide Cohort Study of Risk for Death in Patients Taking Ibopamine Hans Feenstra , Rick E. Grobbee , Bas A. in't Veld , and Bruno H.Ch. Stricker Metrics 3 April 2001Volume 134, Issue 7Page: I-95KeywordsBloodCohort studiesComputersDeath ratesDrugsHeart failureLongitudinal studiesPharmacistsRisk management ePublished: 3 April 2001 Issue Published: 3 April 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Peptide Transporters in the Intestine and the Kidney
Authors: F. H. Leibach
Journal: Annual Review of Nutrition (1996)

Even though the existence of a transport process for intact peptides in the brush border membrane of intestinal and renal absorptive epithelial cells has been known for almost three decades, it is only recently that the molecular nature of the proteins responsible for the transport process has been elucidated. Two peptide transporters, PEW 1 and PEPT 2, have been cloned. The cloned transporters catalyze active transport of intact di- and tripeptides and utilize a transmembrane electrochemical H+ gradient as the driving force. The characteristic of H+ coupling makes PEPT 1 and PEPT 2 unique among the transporters thus far identified in mammalian cells. In addition, the peptide transporters have immediate pharmacologic relevance because a number of peptide-like drugs are recognized as substrates by these transporters. Recently, cultured cell lines of intestinal and renal origin that express PEPT 1 and PEPT 2 have been identified. These cell lines are likely to facilitate studies on the regulatory aspects of the peptide transporters.
Data Errors in Table 3
Authors: Idris Evans, Derek Angus, Christopher Seymour
Journal: JAMA (2018)

Victor A. van de Graaf, MD; Julia C. A. Noorduyn, MSc; Nienke W. Willigenburg, PhD; Ise K. Butter, MSc; Arthur de Gast, MD, PhD; Ben W. Mol, MD, PhD; Daniel B. F. Saris, MD, PhD; Jos W. R. Twisk, PhD; Rudolf W. Poolman, MD, PhD; for the ESCAPE Research Group
Reply to Jinna Yao, Henry C.C. Pleass, and Howard M.H. Lau’s Letter to the Editor re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008
Authors: Andrea Gallioli, Angelo Territo, Alberto Breda
Journal: European Urology (2020)
Liver Disease
Authors: Jack O. Haller
Journal: JAMA (1971)

This small monograph offers its reader an excellent review of both normal and abnormal liver function. Dr. Paton has brought controversial and difficult problems to light through the use of precise and carefully phrased definitions, excellent drawings, and electron micrographs. The topics covered were well chosen. They include hepatitis, cholangitis, a lengthy discussion of hepatic failure, and a chapter on the methods available for investigation and assay of liver function. Allusions to new topics such as Australian antigen and alphatoxins whet the appetite for further reading. Although concisely written and clearly illustrated,<i>Liver Disease</i>contains a number of disturbing features. The initial chapter on liver function and structure fails to provide a clear understanding of the liver's complex nature. This would be remedied by less emphasis on metabolic pathways and a more detailed histological description. Dr. Paton also makes a number of provocative statements on recent advances in various areas
Suspense
Authors: Gaetan Sgro
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE RADICAL TREATMENT OF SPINA BIFIDA.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ITALY
Journal: JAMA (1927)

<h3>Study Tour for Physicians</h3> The fifth study tour of Italian health resorts, for physicians, organized by the Ente nazionale industrie touristiche, for the purpose of giving Italian physicians a first-hand knowledge of our watering places and seaside resorts, will be conducted from June 27 to July 4. The tour will begin at Riva del Garda and end at Domodossola, some taking the special train and some traveling by automobile. The resorts to be visited on the way are Riva, Arco, Terme di Cornano, Rabbi, Peco, Casino Boaria, San Pellegrino, Fonte Bracca and Bognanco. At each of the resorts an illustrated medical lecture will be held, following which the buildings and equipment will be inspected. <h3>Competitive Prize Offerings</h3> The Royal Academy of Science in Bologna has announced the tenth international contest for the biennial prize of $180 established by its corresponding member Professor De Cyon. Any of a list of subjects
Trichloroethylene Anæsthesia
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SURGERY.
Journal: JAMA (1885)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CORRECTION
Authors: Patrick White
Journal: Thorax (2007)

one year cessation rate in smokers with AL was 10.8% versus 8.4% in smokers with NLF (NS).''Why are these findings being interpreted over-optimistically as evidence of the value of screening for mild COPD?The most likely reason is wishful thinking, since the evidence suggests the opposite conclusion to that supported in the editorial by Mannino.Perhaps it simply arises from the frustrating recognition that COPD is common in adults but is predominantly undiagnosed.There is a serious consequence from promoting early detection of COPD if there is no evidence that it makes any difference.Putting resources into spirometry for the early detection of COPD draws resources from more effective work, the most compelling of which in this context is general smoking cessation.In the study by Bednarek et al, 1 71 people needed to be screened for every additional 1 year smoking quit achieved.This is equivalent to a cost of about J650 per additional smoking quitter.Smoking cessation is the most important intervention in the primary and secondary prevention of COPD.It is equally important in the primary and secondary prevention of cardiovascular disease and many cancers including lung cancer.Until there is some definite advantage to be gained from the early detection of COPD in improving cessation rates among smokers, there is no justification for promoting spirometric screening for mild COPD as a separate public health strategy.On current evidence, screening to detect mild COPD is not warranted and will waste resources that would be better employed to promote smoking cessation in general.
Comprehensive genomic profiling (CGP) of thymic gland carcinomas
Authors: J. Creeden, J. Ross, P. Vanden Borre, N. Almog, A. Schrock, J. Chung, J-A Vergilio, J. Suh, S. Ramkissoon, S. Ali, V. Miller, P. Stephens, J. Elvin, L. Gay
Journal: Annals of Oncology (2017)
Gladys
Authors: Nancy Naomi Carlson
Journal: JAMA (2009)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal